|
KMID : 0363220100480100872
|
|
Korean Journal of Dermatology
2010 Volume.48 No. 10 p.872 ~ p.875
|
|
|
Erlotinib HCL (Tarceva(R)) Induced Radiation Recall Dermatitis
|
|
Kim Hwa-Mi
Lee Seung-Hun
Kim Chi-Yeon
|
|
|
Abstract
|
|
|
|
Erlotinib (Tarcevaⓡ) is a new anti-cancer agent that acts by inhibiting epidermal growth factor receptor (EGFR) signal transduction. It is currently used in the treatment of advanced stage non-small cell lung cancer and pancreatic cancer. A patient consulted our clinic and she had erythematous patches and vesicles on the submandibular area. She had taken erlotinib for the treatment of recurred lung cancer for 2 weeks. We report here on a case of radiation recall dermatitis that was induced by erlotinib in a 69-year-old woman who was previously irradiated on her submandibular area.
|
|
|
KEYWORD
|
|
|
Epidermal growth factor receptor, Erlotinib, Radiation recall dermatitis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|